These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7272177)

  • 1. Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to intravenous tyramine in man.
    Martini A; Bonollo L; Nicolis FB; Sega R; Palermo A; Braibanti E
    Br J Clin Pharmacol; 1981 Jun; 11(6):605-10. PubMed ID: 7272177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to oral tyramine in man.
    Martini A; Bonollo L; Nicolis FB; Sega R; Palermo A
    Br J Clin Pharmacol; 1981 Jun; 11(6):611-5. PubMed ID: 7272178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine].
    Andreeva NI; Golovina SM; Faermark MF; Shvarts GIa; Mashkovskiĭ MD
    Farmakol Toksikol; 1991; 54(2):38-40. PubMed ID: 1884793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors.
    Zimmer R
    Acta Psychiatr Scand Suppl; 1990; 360():81-3. PubMed ID: 2248084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of caroxazone, a new antidepressant drug, on monoamine oxidases in healthy volunteers.
    Moretti A; Caccia C; Martini A; Bonollo L; Amico A; Sega R; Nicolella V; Nicolis FB
    Br J Clin Pharmacol; 1981 May; 11(5):511-5. PubMed ID: 7272163
    [No Abstract]   [Full Text] [Related]  

  • 6. Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits.
    Weinstock M; Gorodetsky E; Wang RH; Gross A; Weinreb O; Youdim MB
    Neuropharmacology; 2002 Nov; 43(6):999-1005. PubMed ID: 12423669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypotensive action and weak potentiation of tyramine effect by moclobemide in rats.
    Da Prada M; Burkard WP
    Acta Psychiatr Scand Suppl; 1990; 360():106-7. PubMed ID: 2248060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of food on the tyramine pressor effect during chronic moclobemide treatment of healthy volunteers.
    Audebert C; Blin O; Monjanel-Mouterde S; Auquier P; Pedarriosse AM; Dingemanse J; Durand A; Cano JP
    Eur J Clin Pharmacol; 1992; 43(5):507-12. PubMed ID: 1483487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyramine kinetics and pressor sensitivity during monoamine oxidase inhibition by selegiline.
    Schulz R; Antonin KH; Hoffmann E; Jedrychowski M; Nilsson E; Schick C; Bieck PR
    Clin Pharmacol Ther; 1989 Nov; 46(5):528-36. PubMed ID: 2510962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pressor response to intravenous tyramine in healthy subjects after safinamide, a novel neuroprotectant with selective, reversible monoamine oxidase B inhibition.
    Cattaneo C; Caccia C; Marzo A; Maj R; Fariello RG
    Clin Neuropharmacol; 2003; 26(4):213-7. PubMed ID: 12897643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyramine infusions and selective monoamine oxidase inhibitor treatment. II. Interrelationships among pressor sensitivity changes, platelet MAO inhibition, and plasma MHPG reduction.
    Pickar D; Cohen RM; Jimerson DC; Lake CR; Murphy DL
    Psychopharmacology (Berl); 1981; 74(1):8-12. PubMed ID: 6791210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular sympathomimetic amine interactions in rats treated with monoamine oxidase inhibitors and the novel oxazolidinone antibiotic linezolid.
    Humphrey SJ; Curry JT; Turman CN; Stryd RP
    J Cardiovasc Pharmacol; 2001 May; 37(5):548-63. PubMed ID: 11336106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. limited potentiation of blood pressure in response to oral tyramine by the anti-Parkinson brain selective multifunctional monoamine oxidase-AB inhibitor, M30.
    Gal S; Abassi ZA; Youdim MB
    Neurotox Res; 2010 Aug; 18(2):143-50. PubMed ID: 19894083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoamine oxidase inhibitors and pressor response to dietary amines].
    Tipton KF
    Vopr Med Khim; 1997; 43(6):494-503. PubMed ID: 9503566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some basic aspects of reversible inhibitors of monoamine oxidase-A.
    Da Prada M; Kettler R; Burkard WP; Lorez HP; Haefely W
    Acta Psychiatr Scand Suppl; 1990; 360():7-12. PubMed ID: 2248079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyramine infusions and selective monoamine oxidase inhibitor treatment. I. Changes in pressor sensitivity.
    Pickar D; Cohen RM; Jimerson DC; Murphy DL
    Psychopharmacology (Berl); 1981; 74(1):4-7. PubMed ID: 6791202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB; Weinstock M
    Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of various monoamine oxidase (MAO) inhibitors on the response of blood pressure of rats and cats to tyramine.
    Abdo-Rubo A
    Acta Physiol Hung; 1990; 75(4):321-36. PubMed ID: 2127505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic interaction between toloxatone, a new reversible monoamine oxidase-A inhibitor, and oral tyramine in healthy subjects.
    Provost JC; Funck-Brentano C; Rovei V; D'Estanque J; Ego D; Jaillon P
    Clin Pharmacol Ther; 1992 Oct; 52(4):384-93. PubMed ID: 1424410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a novel monoamine-oxidase inhibitor, moclobemide on the sensitivity to intravenous tyramine and norepinephrine in humans.
    Cusson JR; Goldenberg E; Larochelle P
    J Clin Pharmacol; 1991 May; 31(5):462-7. PubMed ID: 2050833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.